Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations
- PMID: 16504560
- DOI: 10.1016/j.jmgm.2006.01.004
Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations
Abstract
To understand the basis of drug resistance, particularly of the HIV-1 PR, three molecular dynamics (MD) simulations of HIV-1 PR mutant species, G48V, complexed with saquinavir (SQV) in explicit aqueous solution with three protonation states, diprotonation on Asp25 and Asp25' (Di-pro) and monoprotonation on each Asp residue (Mono-25 and Mono-25'). For all three states, H-bonds between saquinavir and HIV-1 PR were formed only in the two regions, flap and active site. It was found that conformation of P2 subsite of SQV in the Mono-25 state differs substantially from the other two states. The rotation about 177 degrees from the optimal structure of the wild type was observed, the hydrogen bond between P2 and the flap residue (Val48) was broken and indirect hydrogen bonds with the three residues (Asp29, Gly27, and Asp30) were found instead. In terms of complexation energies, interaction energy of -37.3 kcal/mol for the Mono-25 state is significantly lower than those of -30.7 and -10.7kcal/mol for the Mono-25' and Di-pro states, respectively. It was found also that protonation at the Asp25 leads to a better arrangement in the catalytic dyad, i.e., the Asp25-Asp25' interaction energy of -8.8 kcal/mol of the Mono-25 is significantly lower than that of -2.6kcal/mol for the Mono-25' state. The above data suggest us to conclude that interaction in the catalytic area should be used as criteria to enhance capability in drug designing and drug screening instead of using the total inhibitor/enzyme interaction.
Similar articles
-
Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.J Chem Inf Model. 2005 Mar-Apr;45(2):300-8. doi: 10.1021/ci049784g. J Chem Inf Model. 2005. PMID: 15807491
-
Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.J Mol Graph Model. 2007 Sep;26(2):558-70. doi: 10.1016/j.jmgm.2007.03.013. Epub 2007 Apr 4. J Mol Graph Model. 2007. PMID: 17468026
-
Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/L90M mutants based on QM and QM/MM calculations.J Mol Graph Model. 2007 Nov;26(4):720-7. doi: 10.1016/j.jmgm.2007.04.009. Epub 2007 May 3. J Mol Graph Model. 2007. PMID: 17543558
-
Understanding HIV protease: can it be translated into effective therapy against AIDS?Scand J Clin Lab Invest Suppl. 1992;210:127-35. Scand J Clin Lab Invest Suppl. 1992. PMID: 1455175 Review.
-
The active site of HIV-1 protease.Med Res Rev. 2001 Jul;21(4):348-53. doi: 10.1002/med.1012. Med Res Rev. 2001. PMID: 11410934 Review.
Cited by
-
Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.Drug Discov Today. 2010 Mar;15(5-6):186-97. doi: 10.1016/j.drudis.2010.01.004. Epub 2010 Jan 22. Drug Discov Today. 2010. PMID: 20096804 Free PMC article. Review.
-
AMPK: a cellular metabolic and redox sensor. A minireview.Front Biosci (Landmark Ed). 2014 Jan 1;19(3):447-74. doi: 10.2741/4218. Front Biosci (Landmark Ed). 2014. PMID: 24389195 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials